Halsin Partners retweeted
Kurma Partners closes Biofund IV at €215M, giving European biotech a fresh specialist pool of capital
european-biotechnology.com/l…
Kurma Partners has closed Biofund IV at €215 million, giving European biotech founders a meaningful new source of capital even though the vehicle...
Halsin Partners retweeted
A great conversation with Christopher Leidli on @RxForBiotech - discussing the future of oncology, innovation and our approach of old drugs new at #AVCT and the next chapter with FOCUS-01
So excited for the future
#FOCUSOnTheWin
#HopeWithoutCompromise
linkedin.com/posts/biotechgu…
Halsin Partners retweeted
#Basel-based #FoRxTherapeutics, a clinical-stage #BioTech company developing precision anti-#cancer therapeutics, today announced the close of an insider-led €42 million #SeriesA financing 🇨🇭 🧬
eu-startups.com/2025/12/swis…
Halsin Partners retweeted
Just out in @NatureBiotech - a deep dive into what's next in idiopathic pulmonary fibrosis after the approval of @Boehringer 's Jascayd (nerandomilast). There's still huge scope for innovation here - & many good ideas being pursued. nature.com/articles/s41587-0…
Halsin Partners retweeted
Sanofi and Orano Med’s radiopharma AlphaMedix met both primary endpoints in Phase 2 for a rare type of cancer, suggesting tumor shrinkage and prolonged benefits.
endpoints.news/sanofi-and-ra…
Halsin Partners retweeted
Addex sieht sich nach zweitem Quartal auf Kurs brnw.ch/21wWcUY
Halsin Partners retweeted
The French biotech startup EG 427 has made a gene therpay based on a herpesvirus vector that delivers a botulinum toxin to sensory neurons to reduce urinary incontinence by 88% in spinal cord injury patients. Read more in my exclusive for @endpts - endpoints.news/exclusive-fre…
Halsin Partners retweeted
The Dementia Disparity: Rethinking Alzheimer’s Through The Female Lens — Click the image below to read more! || #InVivo | Start your free trial today: vist.ly/43pj6 vist.ly/43pj7
Halsin Partners retweeted
Podcast: Scancell’s Cancer Vaccine Progress With NHS Partnership — Click the image below to read more! || #InVivo | Start your free trial today: vist.ly/3yqbe vist.ly/3yqbf
Halsin Partners retweeted
We are excited to lead a CHF2 million investment in @stalicla_sa , a fellow clinical-stage Swiss biotech focused on precision medicine for neurodevelopmental and neuropsychiatric disorders. This strategic investment supports our commitment to advancing innovative treatments
Halsin Partners retweeted
On Saturday, Mikhail Kalinichev, our Head of Translational Science will present the progress we’ve made in our GABAB PAM cough program at the 10th American Cough Conference.
Halsin Partners retweeted
In Brief: Bioxodes To Take Novel Hemorrhagic Stroke Drug Into Registrational Trial ow.ly/oRJC1066QYw #PharmaScrip
Halsin Partners retweeted
Tomorrow we will issue our Full-Year 2024 Financial Results. Our CEO, Tim Dyer, and Mikhail Kalinichev, Head of Translational Science, will host a conference call and webcast at 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT) to discuss the results and provide a corporate update.
Halsin Partners retweeted
On World Parkinson’s Day, we recognize all the individuals, their families, and caregivers who are all impacted significantly by this debilitating disease. #Parkinson’s disease is a progressive and debilitating neurological disorder affecting millions of people worldwide.
Halsin Partners retweeted
New study demonstrates benefit of Neo Medical’s spine surgery tech
Neo Medical’s Force Control technology has proven to reduce implant-related revision surgeries by 58%.
medicaldevice-network.com/ne…
Halsin Partners retweeted
Join us in Chicago at the American Association for Cancer Research (AACR) Annual Meeting 2025, from April 25-30!
👉investors.molecularpartners.…
#Cancer #Oncology #AACR2025 #DARPin #RadioDARPin
Halsin Partners retweeted
Could spray-dried RNA vaccines formulated for nasal administration be the key to unlocking access to RNA-based vaccines? 🔓💉
CEPI is providing $5 million to @ethris_mRNA to find out.
Learn more ⬇️
cepi.net/cepi-partners-ethri…
Halsin Partners retweeted
Thanks @ScripEleanor Eleanor Malone for including predictions from our CEO, Tim Dyer, in your recent @PharmaScrip Scrip Asks feature on #biopharma funding and partnering!
insights.citeline.com/scrip/…
Halsin Partners retweeted
Alithea Genomics Launches Full-Length DRUG-Seq to Unlock Full Power of Transcriptomics for Drug Discovery dlvr.it/TGd8Pv
Halsin Partners retweeted
Neo Medical Proclaims EU MDR Portfolio Success
bit.ly/4f5KvQC




















